Shandong Polymer Biochemicals Co., Ltd. (SHE:002476)
China · Delayed Price · Currency is CNY 6.24
+0.01 (0.16%)
Feb 13, 2026, 3:04 PM CST
SHE:002476 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 603.62 | 536.9 | 385.16 | 590.28 | 529.73 | 446.31 |
Other Revenue | 1.76 | 1.76 | 2.17 | 2.01 | 127.43 | 1.01 |
| 605.38 | 538.66 | 387.34 | 592.28 | 657.16 | 447.31 | |
Revenue Growth (YoY) | 30.83% | 39.07% | -34.60% | -9.87% | 46.91% | 7.30% |
Cost of Revenue | 495.3 | 441.45 | 322.27 | 463.09 | 557.07 | 363.91 |
Gross Profit | 110.08 | 97.21 | 65.07 | 129.19 | 100.09 | 83.41 |
Selling, General & Admin | 58.57 | 58.71 | 68.26 | 71.92 | 51.87 | 37.57 |
Research & Development | 19.41 | 20.39 | 17.98 | 25.49 | 22.4 | 17.92 |
Other Operating Expenses | 1.28 | 0.83 | 4.37 | 5.14 | 4.26 | 3.35 |
Operating Expenses | 75.74 | 81.08 | 83.88 | 104.37 | 80.41 | 58.71 |
Operating Income | 34.33 | 16.13 | -18.81 | 24.82 | 19.68 | 24.69 |
Interest Expense | -1.54 | -0.93 | -0.64 | -0.48 | -4.75 | -9.73 |
Interest & Investment Income | 52.21 | 50.13 | 6.05 | 6.68 | 5.38 | 5.57 |
Currency Exchange Gain (Loss) | 1.01 | 1.01 | 1.68 | 5.06 | -0.6 | -2.26 |
Other Non Operating Income (Expenses) | -15.21 | -11.23 | -2.8 | -0.14 | -0.49 | 0.07 |
EBT Excluding Unusual Items | 70.8 | 55.11 | -14.51 | 35.94 | 19.23 | 18.34 |
Gain (Loss) on Sale of Investments | - | - | -1.33 | -8.02 | -2.59 | -1.64 |
Gain (Loss) on Sale of Assets | 0.62 | 0.73 | 25.22 | 1.11 | -0.14 | 0.02 |
Asset Writedown | -0.85 | -0.71 | - | - | -0.32 | -0.06 |
Other Unusual Items | 8.93 | 6.64 | 1.26 | 2.04 | 1.52 | 0.4 |
Pretax Income | 79.5 | 61.78 | 10.64 | 31.08 | 17.7 | 17.05 |
Income Tax Expense | 8.61 | 5.38 | 5.4 | 1.37 | -0.25 | 3.87 |
Earnings From Continuing Operations | 70.89 | 56.39 | 5.23 | 29.7 | 17.95 | 13.18 |
Net Income | 70.89 | 56.39 | 5.23 | 29.7 | 17.95 | 13.18 |
Net Income to Common | 70.89 | 56.39 | 5.23 | 29.7 | 17.95 | 13.18 |
Net Income Growth | 145.86% | 977.59% | -82.38% | 65.49% | 36.15% | -85.55% |
Shares Outstanding (Basic) | 612 | 612 | 609 | 612 | 613 | 613 |
Shares Outstanding (Diluted) | 612 | 612 | 609 | 612 | 613 | 613 |
Shares Change (YoY) | -2.23% | 0.62% | -0.64% | -0.02% | -0.10% | 0.19% |
EPS (Basic) | 0.12 | 0.09 | 0.01 | 0.05 | 0.03 | 0.02 |
EPS (Diluted) | 0.12 | 0.09 | 0.01 | 0.05 | 0.03 | 0.02 |
EPS Growth | 151.46% | 970.93% | -82.27% | 65.53% | 36.28% | -85.58% |
Free Cash Flow | -3.59 | 24.59 | 114 | -93.18 | -54.04 | 14.85 |
Free Cash Flow Per Share | -0.01 | 0.04 | 0.19 | -0.15 | -0.09 | 0.02 |
Dividend Per Share | 0.010 | 0.010 | 0.010 | - | - | - |
Gross Margin | 18.18% | 18.05% | 16.80% | 21.81% | 15.23% | 18.65% |
Operating Margin | 5.67% | 3.00% | -4.86% | 4.19% | 3.00% | 5.52% |
Profit Margin | 11.71% | 10.47% | 1.35% | 5.01% | 2.73% | 2.95% |
Free Cash Flow Margin | -0.59% | 4.57% | 29.43% | -15.73% | -8.22% | 3.32% |
EBITDA | 52.52 | 36.29 | 3.98 | 57.91 | 53.19 | 65.31 |
EBITDA Margin | 8.67% | 6.74% | 1.03% | 9.78% | 8.09% | 14.60% |
D&A For EBITDA | 18.18 | 20.16 | 22.79 | 33.09 | 33.51 | 40.61 |
EBIT | 34.33 | 16.13 | -18.81 | 24.82 | 19.68 | 24.69 |
EBIT Margin | 5.67% | 3.00% | -4.86% | 4.19% | 3.00% | 5.52% |
Effective Tax Rate | 10.83% | 8.71% | 50.80% | 4.42% | - | 22.68% |
Revenue as Reported | 605.38 | 538.66 | 387.34 | 592.28 | 657.16 | 447.31 |
Advertising Expenses | - | 0.29 | 2.65 | 2.47 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.